PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION

NEW YORK, March  26, 2025  (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Profound Medical Corp. (NASDAQ: PROF) (“Profound” or the “Company”).

The investigation concerns whether and certain of its officers and/or directors have engaged in securities fraud.

PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION

Profound disclosed in an SEC filing on March 7, 2025, that "the Company identified an error which overstated revenue by $472,000 in the first quarter of 2024." The Company admitted that its quarterly reports for the first three quarters of 2024 could no longer be relied upon by investors.

Based on this news, shares of Profound fell by 5.9% on the same day.

Wolf Haldenstein has experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas, and offices in New York, Chicago, Nashville and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly lauded by the courts, which have appointed it to major positions in complex securities, multi-district and consolidated litigation.

If you wish to discuss this investigation or have any questions regarding your rights and interests, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735 or via e-mail at [email protected].

Contact:

Wolf Haldenstein Adler Freeman & Herz LLP
Gregory Stone, Director of Case and Financial Analysis
Email: [email protected] or [email protected]
Tel: (800) 575-0735 or (212) 545-4774

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.